Figure 3
From: 89Zr-panitumumab PET imaging for preoperative assessment of ameloblastoma in a PDX model
In vivo PET/CT imaging of ameloblastoma tumors. Representative MicroPET/CT images were obtained 7 days post injection. All animal received 89Zr-panitumumab. The blocking group (+ block) also received an unlabeled dose of panitumumab. Tumors were implanted in the flanks of mice. Maximum intensity is demonstrated in the upper panels, and the axial slice at the center of the tumor is shown in the bottom panels (as indicated by arrow). The scale, expressed as standardized uptake value (SUV), is at the far right.
